  Serum Institute of India Ltd. (SII Ltd., Pune, India, 

) has  developed a vaccine against Hib (Haemophilus influenza type b) and obtained a  license from the Indian Government for its production. The pilot process  technology know-how came from the Netherlands Vaccine Institute (NVI, Bilthoven, the Netherlands, 

). This is the first time  that through intensive joint development and technology transfer a developing  country vaccine manufacturer has developed a Hib vaccine successfully and  obtained a license for it.

News

Serum Institute of India Ltd. (SII Ltd., Pune, India, www.seruminstitute.com) has developed a vaccine against Hib (Haemophilus influenza type b) and obtained a license from the Indian Government for its production.